investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
EGFR T790M-mediated drug resistance in non-small cell lung cancer
Pinar Ozden Eser
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Eric B. Haura
AN ACTIVE ROLE OF ADAPTOR PROTEINS IN TYROSINE KINASE INHIBITOR RESISTANCE
Trachea, bronchus and lung
Nathanael Schiander Gray
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
Trachea, bronchus and lung
Brid Ryan
Examining Novel Roles of Nicotine and Tobacco Smoke on RNA Biology
Trachea, bronchus and lung
Pathology
Jonathan M Kurie
Regulation of Lung Cancer Metastasis by miR-200
Trachea, bronchus and lung
Peter S Hammerman
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
Trachea, bronchus and lung
Kim O'Neill
Cancer Immunology Research at Brigham Young University
Trachea, bronchus and lung
Bakhos A Tannous
Detection of NSCLC-derived Mutant RNA in Platelets
Trachea, bronchus and lung
Pathology
Lesley Katie Seymour
LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P
Trachea, bronchus and lung
Pathology
Charles M. Rudin
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
Trachea, bronchus and lung